Curing Cancer with p53
- 24 June 2004
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 350 (26), 2711-2712
- https://doi.org/10.1056/nejmcibr041288
Abstract
The tumor-suppressor protein p53 is mutant in a large proportion of many cancers; a recent study bolsters hope that p53-targeted therapy can be devised.This publication has 4 references indexed in Scilit:
- Treatment of Terminal Peritoneal Carcinomatosis by a Transducible p53-Activating PeptidePLoS Biology, 2004
- Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosisNature Medicine, 2004
- Surfing the p53 networkNature, 2000
- Small peptides activate the latent sequence-specific DNA binding function of p53Cell, 1995